In April I will have my last Tysabri infusion. 30 days later I will switch to Arbagio.
The DMT switch from Ty to Arbagio is part of a research study of the 3 oral MS meds, Tecfidera, Gilenya and Arbagio. It's to compare effectiveness of the meds, but also because the 2 doc presented the same proposal requesting very close screening of MS patients.
The study consist of monthly 3D-MRIs, blood work to screen for those ineligible for Arbagio and monthly? blood work and MS Neuro office visit, and cost of Arbagio.
There are 2 MS clinics included in the study, Harvard and my MS clinic doc.
I'm real apprehensive about stopping Ty, but my doc's practice is going in another DMT direction it seems.
I would like to hear from anyone who is or will be participating in this study. I assume wer're a small group represented here because of the limited scope of the study.
Anyone else participating in this study?
The DMT switch from Ty to Arbagio is part of a research study of the 3 oral MS meds, Tecfidera, Gilenya and Arbagio. It's to compare effectiveness of the meds, but also because the 2 doc presented the same proposal requesting very close screening of MS patients.
The study consist of monthly 3D-MRIs, blood work to screen for those ineligible for Arbagio and monthly? blood work and MS Neuro office visit, and cost of Arbagio.
There are 2 MS clinics included in the study, Harvard and my MS clinic doc.
I'm real apprehensive about stopping Ty, but my doc's practice is going in another DMT direction it seems.
I would like to hear from anyone who is or will be participating in this study. I assume wer're a small group represented here because of the limited scope of the study.
Anyone else participating in this study?
Comment